Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies.

Cancer Med · 2015 · PMC4430263 · PMID 25619980

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

approaching significanceP = 0.068so close (0.05 < p ≤ 0.1)

The only biomarker approaching significance was pEGFR at 24 h ( P = 0.068), with the sensitive group demonstrating decreased pEGFR expression relative to control (89.3% (95% CI: 36.1%, 142.5%) while the resistant group had a higher level of pEGFR (137.7% (95% CI: 101.4%, 173.9%).

also in 1,455 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.